NewsRoom Articles - Page 206 of 222

TuesdaySep 22, 2020 1:00 pm

Infectious Disease Expert Provides Overview of Biomedical Research Process

Since the COVID-19 crisis was declared a pandemic by the World Health Organization, it has claimed the lives of more than 958,000 people worldwide. The disease was caused by the SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2). Across the globe, researchers, public health experts and clinicians have dedicated their energy, time and expertise to the coronavirus pandemic in an effort to rid society of this disease and restore a sense of normalcy from the warped times we now live in. In the past 7 months, scientists have discovered and learnt a lot about the virus and the disease it…

MondaySep 21, 2020 3:25 pm

Could Your Hormones Be Making You Sick?

A recent study by researchers from Michigan State University shows that various differences in biological sex can determine long-term disease patterns, which may link specific hormones that were present before and after birth with a body’s immune responses as well as its long-term immunological disease growth. The study, which was published in the Proceedings of National Academy of Sciences, discussed various reasons why females are more at risk for various common diseases that involve the immune system such as migraines, allergies, irritable bowel syndrome and asthma. The study findings by Emily Mackey, Adam Moeser and Cynthia Jordan usher in new…

MondaySep 21, 2020 2:10 pm

KBL Merger Corp. IV (NASDAQ: KBLM) (NASDAQ: KBLMR) (NASDAQ: KBLMW) Fulfilling IPO Goal Through Merger With 180 Life Sciences Corp.

KBL Merger Corp. IV is set to finalize the acquisition of 180 Life Sciences Corp. during Q4 2020 180 Life Sciences Corp. has several ongoing programs at different stages of development, with the leading candidate in Phase 2b/3, helping mitigate the risks involved with its drug development The merger with 180 Life Sciences will enable KBL Merger Corp. IV to enter a market expected to double in size by 2027 180 Life Sciences is growing its patent portfolio through several preclinical studies beginning in two additional areas of inflammatory novel drug studies KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp.…

MondaySep 21, 2020 11:15 am

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary’s CIO Discusses Curing Cancer with AI on DojoLIVE! Interview

POAI subsidiary Helomics exec discusses the company’s quest to fight cancer Helomics tapping into the fast growing, billion-dollar AI in drug discovery market Pittsburgh-based company has been building foundational groundwork in cancer drug response profiling for two decades Helomics harnesses rich historic tumor data with the power of AI to test living tumor tissues Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its executives, Helomics CIO Mark Collins, PhD, recently appeared on DojoLIVE! (https://ibn.fm/hSAn4). Helomics, a POAI subsidiary, applies artificial intelligence to its rich data gathered…

MondaySep 21, 2020 11:00 am

Important Coronavirus Pandemic Lessons for the Diagnostics Industry

As we all know by now, the best way to help stop the spread of coronavirus is getting a coronavirus test done and wearing a mask, of course. A test reveals whether a person is negative or positive. A negative test result means an individual does not have the virus while a positive result means that one does have the virus. As we have seen, a positive rest result warrants quarantine for a 2-week period during which an individual is observed or treated, depending on the severity of their symptoms. Around the world, 200 million tests have been performed. However,…

FridaySep 18, 2020 12:45 pm

How Genetics Influence Episodic and Chronic Migraines

According to statistics, migraines are a common ailment as about 15% of the world’s population suffer from them at least once in their lives or frequently. In Russia, the rate is at 20%. Currently, the diagnosis and treatment methods of migraines are based on a patient’s grievances. The Gene and Cell Technologies Lab and the KFU Neurobiology Lab conducted this research. For a period of 2 years, the team studied individuals for genetic markers of migraines. Their colleagues from the Kazan State Medical University and Saint Petersburg also contributed to this research study. Aliya Yakubova, a Neurologist and junior research…

FridaySep 18, 2020 9:00 am

4 Face Mask Myths

The Centers for Disease Control and Prevention (“CDC”) recently stated that “Cloth face coverings are one of the most powerful weapons we have to slow and stop the spread of the virus,” (https://ibn.fm/1yiUN). However, there are people that believe alternative sources, or unsubstantiated myths, such as those listed below. Wearing a mask causes carbon dioxide build-up, especially when worn for a long period of time Some people claim they won’t be able to breathe if they have a mask on. However, there is no scientific truth behind this claim. Take for instance, health care workers, who wear masks for many…

ThursdaySep 17, 2020 2:45 pm

Researchers Study Whether Soy Could Improve the Treatment of Bone Cancer

In recent years, researchers have demonstrated the various health benefits that soy possesses. Some have linked the consumption of soy to reduced cancer, obesity as well as improved bone health. Now researchers from WSU are planning to utilize the benefits of soy to help better postoperative bone cancer treatment. In the Acta Biomaterialia journal, Naboneeta Sarkar, a graduate student and Susmita Bose, professor from the school of Mechanical and Materials Engineering, WSU, demonstrated that the steady release of chemical compounds that are soy-based from a bone-structure that was 3D printed led to the decrease of osteosarcoma cells as well as…

ThursdaySep 17, 2020 11:45 am

AI Helps Scientists Examine Gene Activation

Scientists from UC, San Diego have finally worked out an enigma in human gene activation. As illustrated in the journal Nature, this discovery may be used to control gene activation in biomedical and biotechnology applications. For a long time, scientists have known that the human genes act using instructions that are delivered by the specific order of a human’s DNA. This is directed by the 4 types of individual links, coded C, A, T and G. About 25% of a human’s genes are transcribed in sequences resembling TATAAA, which is referred to as the TATA box. However, for the remaining…

ThursdaySep 17, 2020 11:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Sub-Licensee Partner Announces CRO for Phase 1 and Phase 2 Berubicin Trials in Poland

Poland trials will include the first ever Phase 1 trial for pediatric patients suffering from glioblastoma multiforme CNS Pharmaceuticals has made significant strides in its Berubicin manufacturing process due to its dual-track approach and expects to begin production of its drug candidate at Pharmaceuticals International during the third quarter of 2020 The Company’s CFO recently acquired 142,000 shares of common stock in the open market, a move indicative of his confidence in the success of Berubicin clinical trials and its positive impact on the global brain tumor therapeutics market CNS Pharmaceuticals (NASDAQ: CNSP) is moving forward with clinical trials of…